Vincent J. Angotti, Chief Executive Officer at ACELRX PHARMACEUTICALS INC (ACRX), bought 10,000 shares at $0.73 ($7K) on 2023-12-13, disclosed to the SEC on 2023-12-14.
Open-market purchase of $7k ACRX by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TLPH | BUY | 2025-04-03 | $252K | — | Filing → |
| TLPH | BUY | 2024-12-06 | $3K | — | Filing → |
| TLPH | BUY | 2024-12-02 | $4K | — | Filing → |